Global Drugs for Vulvovaginal Candidiasis Market Status and Outlook 2018-2025

August 2018 | 134 pages | ID: GF4D2506C64EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Bayer
• Perrigo
• J & J
• Pfizer
• Bristol-Myers Squibb
• Effik
• Teva
• Sanofi
• Cisen Pharmaceutical
• Kingyork Group

Market by Type

• Miconazole
• Clotrimazole
• Fluconazole
• Econazole
• Other

Market by Application

• Hospital & Clinic
• Pharmacy

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Drugs for Vulvovaginal Candidiasis Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Miconazole
  3.1.2 Clotrimazole
  3.1.3 Fluconazole
  3.1.4 Econazole
  3.1.5 Other
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hospital & Clinic
  4.1.2 Pharmacy
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Miconazole Production by Region
    6.1.1.2 Clotrimazole Production by Region
    6.1.1.3 Fluconazole Production by Region
    6.1.1.4 Econazole Production by Region
    6.1.1.5 Other Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hospital & Clinic Production by Region
    6.1.2.2 Pharmacy Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Miconazole Demand by Region
    6.2.1.2 Clotrimazole Demand by Region
    6.2.1.3 Fluconazole Demand by Region
    6.2.1.4 Econazole Demand by Region
    6.2.1.5 Other Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hospital & Clinic Demand by Region
    6.2.2.2 Pharmacy Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Bayer
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Perrigo
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 J & J
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Pfizer
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Bristol-Myers Squibb
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Effik
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Teva
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Sanofi
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Cisen Pharmaceutical
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Kingyork Group
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Drugs for Vulvovaginal Candidiasis Industry Dynamics & Regulations List
Table Global Drugs for Vulvovaginal Candidiasis Sales Revenue, Cost and Margin, 2015-2018E
Table Global Drugs for Vulvovaginal Candidiasis Market Status by Type 2015-2018E, in USD Million
Table Global Drugs for Vulvovaginal Candidiasis Market Status by Application 2015-2018E, in USD Million
Table Global Drugs for Vulvovaginal Candidiasis Market Status by Application 2015-2018E, in Volume
Table Global Drugs for Vulvovaginal Candidiasis Market by Region 2015-2018E, in USD Million
Table Global Drugs for Vulvovaginal Candidiasis Market Share by Region in 2018, in USD Million
Table Global Drugs for Vulvovaginal Candidiasis Market by Region 2015-2018E, in Volume
Table Global Drugs for Vulvovaginal Candidiasis Market Share by Region in 2018, in Volume
Table Miconazole Production Value by Region 2015-2018E, in USD Million
Table Miconazole Production Volume by Region 2015-2018E, in Volume
Table Clotrimazole Production Value by Region 2015-2018E, in USD Million
Table Clotrimazole Production Volume by Region 2015-2018E, in Volume
Table Fluconazole Production Value by Region 2015-2018E, in USD Million
Table Fluconazole Production Volume by Region 2015-2018E, in Volume
Table Econazole Production Value by Region 2015-2018E, in USD Million
Table Econazole Production Volume by Region 2015-2018E, in Volume
Table Other Production Value by Region 2015-2018E, in USD Million
Table Other Production Volume by Region 2015-2018E, in Volume
Table Hospital & Clinic Production Value by Region 2015-2018E, in USD Million
Table Hospital & Clinic Production Volume by Region 2015-2018E, in Volume
Table Pharmacy Production Value by Region 2015-2018E, in USD Million
Table Pharmacy Production Volume by Region 2015-2018E, in Volume
Table Miconazole Market Size by Region 2015-2018E, in USD Million
Table Miconazole Market Size by Region 2015-2018E, in Volume
Table Clotrimazole Market Size by Region 2015-2018E, in USD Million
Table Clotrimazole Market Size by Region 2015-2018E, in Volume
Table Fluconazole Market Size by Region 2015-2018E, in USD Million
Table Fluconazole Market Size by Region 2015-2018E, in Volume
Table Econazole Market Size by Region 2015-2018E, in USD Million
Table Econazole Market Size by Region 2015-2018E, in Volume
Table Other Market Size by Region 2015-2018E, in USD Million
Table Other Market Size by Region 2015-2018E, in Volume
Table Hospital & Clinic Market Size by Region 2015-2018E, in USD Million
Table Hospital & Clinic Market Size by Region 2015-2018E, in Volume
Table Pharmacy Market Size by Region 2015-2018E, in USD Million
Table Pharmacy Market Size by Region 2015-2018E, in Volume
Table GlobalDrugs for Vulvovaginal Candidiasis Forecast by Type 2019F-2025F, in USD Million
Table Drugs for Vulvovaginal Candidiasis Forecast by Type 2019F-2025F, in Volume
Table Drugs for Vulvovaginal Candidiasis Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Drugs for Vulvovaginal Candidiasis Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Drugs for Vulvovaginal Candidiasis Market Forecast by Region 2019F-2025F, in USD Million
Table Drugs for Vulvovaginal Candidiasis Market Forecast by Region 2019F-2025F, in Volume
Table Bayer Information
Table Drugs for Vulvovaginal Candidiasis Sales, Cost, Margin of Bayer
Table Perrigo Information
Table Drugs for Vulvovaginal Candidiasis Sales, Cost, Margin of Perrigo
Table J & J Information
Table Drugs for Vulvovaginal Candidiasis Sales, Cost, Margin of J & J
Table Pfizer Information
Table Drugs for Vulvovaginal Candidiasis Sales, Cost, Margin of Pfizer
Table Bristol-Myers Squibb Information
Table Drugs for Vulvovaginal Candidiasis Sales, Cost, Margin of Bristol-Myers Squibb
Table Effik Information
Table Drugs for Vulvovaginal Candidiasis Sales, Cost, Margin of Effik
Table Teva Information
Table Drugs for Vulvovaginal Candidiasis Sales, Cost, Margin of Teva
Table Sanofi Information
Table Drugs for Vulvovaginal Candidiasis Sales, Cost, Margin of Sanofi
Table Cisen Pharmaceutical Information
Table Drugs for Vulvovaginal Candidiasis Sales, Cost, Margin of Cisen Pharmaceutical
Table Kingyork Group Information
Table Drugs for Vulvovaginal Candidiasis Sales, Cost, Margin of Kingyork Group
Table Global Drugs for Vulvovaginal Candidiasis Sales Revenue by Company 2015-2017, in USD Million
Table Global Drugs for Vulvovaginal Candidiasis Sales Volume by Company 2015-2017, in Volume
Table Global Drugs for Vulvovaginal Candidiasis Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Drugs for Vulvovaginal Candidiasis Picture
Figure Drugs for Vulvovaginal Candidiasis Industry Chain Diagram
Figure Global Drugs for Vulvovaginal Candidiasis Sales Revenue 2015-2018E, in USD Million
Figure Global Drugs for Vulvovaginal Candidiasis Sales Volume 2015-2018E, in Volume
Figure Global Drugs for Vulvovaginal Candidiasis Market Status by Type 2015-2018E, in Volume
Figure North America Drugs for Vulvovaginal Candidiasis Market Size and Growth 2015-2018E, in USD Million
Figure North America Drugs for Vulvovaginal Candidiasis Market Size and Growth 2015-2018E, in Volume
Figure Europe Drugs for Vulvovaginal Candidiasis Market Size and Growth 2015-2018E, in USD Million
Figure Europe Drugs for Vulvovaginal Candidiasis Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Drugs for Vulvovaginal Candidiasis Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Drugs for Vulvovaginal Candidiasis Market Size and Growth 2015-2018E, in Volume
Figure South America Drugs for Vulvovaginal Candidiasis Market Size and Growth 2015-2018E, in USD Million
Figure South America Drugs for Vulvovaginal Candidiasis Market Size and Growth 2015-2018E, in Volume
Figure Middle East Drugs for Vulvovaginal Candidiasis Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Drugs for Vulvovaginal Candidiasis Market Size and Growth 2015-2018E, in Volume
Figure Africa Drugs for Vulvovaginal Candidiasis Market Size and Growth 2015-2018E, in USD Million
Figure Africa Drugs for Vulvovaginal Candidiasis Market Size and Growth 2015-2018E, in Volume
Figure Global Drugs for Vulvovaginal Candidiasis Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Drugs for Vulvovaginal Candidiasis Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Drugs for Vulvovaginal Candidiasis Sales Price Forecast 2019F-2025F
Figure Global Drugs for Vulvovaginal Candidiasis Gross Margin Forecast 2019F-2025F
Figure Global Drugs for Vulvovaginal Candidiasis Sales Revenue by Company in 2018, in USD Million
Figure Global Drugs for Vulvovaginal Candidiasis Price by Company in 2018
Figure Global Drugs for Vulvovaginal Candidiasis Gross Margin by Company in 2018